Health IT Analytics May 4, 2021
Geisinger and Shriners Hospitals for Children are working to enhance precision medicine and genomics research.
Healthcare organizations are increasingly looking to expand their precision medicine and genomics research efforts, with two recent partnerships reflecting the industry’s aim to enhance these areas of care.
The National Cancer Institute (NCI) has awarded a five-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer. Researchers from Geisinger and NCI’s Division of Cancer Epidemiology and Genetics (DCEG) will analyze genetic data from Geisinger’s MyCode Community Health Initiative, a precision medicine project with more than 276,000 consented participants.
The investigative team will use a genome-first approach, analyzing data from MyCode participants to identify specific gene variants and then linking that...
Today's Sponsors
Today's Sponsor